Annual Total Liabilities
$170.11 M
+$104.68 M+160.00%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual total liabilities is $170.11 million, with the most recent change of +$104.68 million (+160.00%) on December 31, 2023.
- During the last 3 years, AUPH annual total liabilities has risen by +$114.20 million (+204.25%).
- AUPH annual total liabilities is now at all-time high.
Performance
AUPH Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$161.36 M
+$2.45 M+1.54%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly total liabilities is $161.36 million, with the most recent change of +$2.45 million (+1.54%) on September 30, 2024.
- Over the past year, AUPH quarterly total liabilities has increased by +$2.45 million (+1.54%).
- AUPH quarterly total liabilities is now -5.14% below its all-time high of $170.11 million, reached on December 31, 2023.
Performance
AUPH Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
AUPH Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +160.0% | +1.5% |
| 3 y3 years | +204.3% | +148.8% |
| 5 y5 years | +411.0% | +148.8% |
AUPH Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.7% | -5.1% | +176.4% |
| 5 y | 5-year | at high | +561.9% | -5.1% | +527.8% |
| alltime | all time | at high | >+9999.0% | -5.1% | >+9999.0% |
Aurinia Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $161.36 M(+1.5%) |
| Jun 2024 | - | $158.91 M(+1.1%) |
| Mar 2024 | - | $157.16 M(-7.6%) |
| Dec 2023 | $170.11 M(+160.0%) | $170.11 M(+4.3%) |
| Sep 2023 | - | $163.14 M(+4.2%) |
| Jun 2023 | - | $156.61 M(+155.3%) |
| Mar 2023 | - | $61.35 M(-6.2%) |
| Dec 2022 | $65.42 M(+1.8%) | $65.42 M(+0.9%) |
| Sep 2022 | - | $64.87 M(+11.1%) |
| Jun 2022 | - | $58.38 M(-0.7%) |
| Mar 2022 | - | $58.78 M(-8.6%) |
| Dec 2021 | $64.28 M(+15.0%) | $64.28 M(+3.8%) |
| Sep 2021 | - | $61.89 M(+14.6%) |
| Jun 2021 | - | $54.01 M(+15.3%) |
| Mar 2021 | - | $46.85 M(-16.2%) |
| Dec 2020 | $55.91 M(+117.5%) | $55.91 M(-11.1%) |
| Sep 2020 | - | $62.91 M(+11.9%) |
| Jun 2020 | - | $56.24 M(+9.1%) |
| Mar 2020 | - | $51.56 M(+100.6%) |
| Dec 2019 | $25.70 M(-22.8%) | $25.70 M(-5.2%) |
| Sep 2019 | - | $27.10 M(+6.8%) |
| Jun 2019 | - | $25.37 M(+0.8%) |
| Mar 2019 | - | $25.16 M(-24.4%) |
| Dec 2018 | $33.29 M(+38.1%) | $33.29 M(+2.9%) |
| Sep 2018 | - | $32.35 M(+26.0%) |
| Jun 2018 | - | $25.68 M(+7.2%) |
| Mar 2018 | - | $23.96 M(-0.6%) |
| Dec 2017 | $24.10 M(+14.5%) | $24.10 M(-25.1%) |
| Sep 2017 | - | $32.19 M(+9.7%) |
| Jun 2017 | - | $29.34 M(-37.6%) |
| Mar 2017 | - | $47.03 M(+123.5%) |
| Dec 2016 | $21.05 M(+54.7%) | $21.05 M(+60.1%) |
| Sep 2016 | - | $13.15 M(+23.5%) |
| Jun 2016 | - | $10.65 M(-9.2%) |
| Mar 2016 | - | $11.72 M(-13.8%) |
| Dec 2015 | $13.60 M(-26.5%) | $13.60 M(-11.7%) |
| Sep 2015 | - | $15.40 M(-5.9%) |
| Jun 2015 | - | $16.37 M(-19.9%) |
| Mar 2015 | - | $20.45 M(+10.5%) |
| Dec 2014 | $18.51 M(+87.8%) | $18.51 M(+161.4%) |
| Sep 2014 | - | $7.08 M(-22.3%) |
| Jun 2014 | - | $9.11 M(+5.2%) |
| Mar 2014 | - | $8.65 M(-12.2%) |
| Dec 2013 | $9.85 M(+57.0%) | $9.85 M(-11.2%) |
| Sep 2013 | - | $11.10 M(+64.0%) |
| Jun 2013 | - | $6.77 M(+3.1%) |
| Mar 2013 | - | $6.57 M(+4.6%) |
| Dec 2012 | $6.28 M(-20.7%) | $6.28 M(+13.4%) |
| Sep 2012 | - | $5.53 M(+5.7%) |
| Jun 2012 | - | $5.23 M(+46.0%) |
| Mar 2012 | - | $3.58 M(-54.7%) |
| Dec 2011 | $7.91 M | $7.91 M(+3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $7.66 M(-10.1%) |
| Jun 2011 | - | $8.52 M(-7.7%) |
| Mar 2011 | - | $9.23 M(+134.6%) |
| Dec 2010 | $3.93 M(-17.0%) | $3.93 M(-11.5%) |
| Sep 2010 | - | $4.45 M(+57.4%) |
| Jun 2010 | - | $2.82 M(-26.6%) |
| Mar 2010 | - | $3.85 M(-18.7%) |
| Dec 2009 | $4.74 M(-74.8%) | $4.74 M(+0.1%) |
| Sep 2009 | - | $4.73 M(+34.1%) |
| Jun 2009 | - | $3.53 M(-60.8%) |
| Mar 2009 | - | $8.99 M(-52.1%) |
| Dec 2008 | $18.79 M(+31.8%) | $18.79 M(-4.9%) |
| Sep 2008 | - | $19.77 M(-7.6%) |
| Jun 2008 | - | $21.39 M(+169.5%) |
| Mar 2008 | - | $7.94 M(-44.3%) |
| Dec 2007 | $14.25 M(+36.1%) | $14.25 M(+27.2%) |
| Sep 2007 | - | $11.20 M(-11.6%) |
| Jun 2007 | - | $12.67 M(+24.1%) |
| Mar 2007 | - | $10.21 M(-2.5%) |
| Dec 2006 | $10.47 M(-12.7%) | $10.47 M(-5.9%) |
| Sep 2006 | - | $11.13 M(+3.7%) |
| Jun 2006 | - | $10.73 M(+8.0%) |
| Mar 2006 | - | $9.94 M(-17.1%) |
| Dec 2005 | $11.99 M(+33.6%) | $11.99 M(+35.0%) |
| Sep 2005 | - | $8.88 M(+26.1%) |
| Jun 2005 | - | $7.04 M(-2.6%) |
| Mar 2005 | - | $7.23 M(-19.4%) |
| Dec 2004 | $8.97 M(+52.3%) | $8.97 M(+13.9%) |
| Sep 2004 | - | $7.88 M(+145.9%) |
| Jun 2004 | - | $3.20 M(-42.6%) |
| Mar 2004 | - | $5.58 M(-5.2%) |
| Dec 2003 | $5.89 M(+88.8%) | $5.89 M(+46.0%) |
| Sep 2003 | - | $4.03 M(+6.0%) |
| Jun 2003 | - | $3.80 M(+24.8%) |
| Mar 2003 | - | $3.05 M(-2.3%) |
| Dec 2002 | $3.12 M(+75.3%) | $3.12 M(-0.5%) |
| Sep 2002 | - | $3.14 M(-25.8%) |
| Jun 2002 | - | $4.23 M(+116.3%) |
| Mar 2002 | - | $1.95 M(-51.6%) |
| Dec 2001 | $1.78 M(+47.1%) | - |
| Aug 2001 | - | $4.04 M(+259.4%) |
| May 2001 | - | $1.12 M(+27.1%) |
| Feb 2001 | - | $884.40 K(-26.9%) |
| Nov 2000 | $1.21 M(+27.2%) | $1.21 M(+47.9%) |
| Aug 2000 | - | $818.10 K(-18.3%) |
| May 2000 | - | $1.00 M(+32.1%) |
| Feb 2000 | - | $758.10 K(-20.3%) |
| Nov 1999 | $950.70 K(-60.5%) | $950.70 K(-5.3%) |
| Aug 1999 | - | $1.00 M(-45.2%) |
| May 1999 | - | $1.83 M(+6.2%) |
| Feb 1999 | - | $1.72 M |
| Nov 1998 | $2.41 M | - |
FAQ
- What is Aurinia Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual total liabilities year-on-year change?
- What is Aurinia Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly total liabilities year-on-year change?
What is Aurinia Pharmaceuticals annual total liabilities?
The current annual total liabilities of AUPH is $170.11 M
What is the all time high annual total liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual total liabilities is $170.11 M
What is Aurinia Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, AUPH annual total liabilities has changed by +$104.68 M (+160.00%)
What is Aurinia Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of AUPH is $161.36 M
What is the all time high quarterly total liabilities for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly total liabilities is $170.11 M
What is Aurinia Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, AUPH quarterly total liabilities has changed by +$2.45 M (+1.54%)